$315 Million is the total value of Eagle Health Investments LP's 27 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 6.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $27,001,000 | +12.8% | 449,565 | +12.5% | 8.56% | +4.2% |
| HUM | Buy | HUMANA INC | $26,665,000 | +26.2% | 68,521 | +43.6% | 8.46% | +16.7% |
| IQV | Sell | IQVIA HLDGS INC | $19,445,000 | -5.9% | 81,177 | -4.8% | 6.17% | -13.0% |
| NTRA | Buy | NATERA INC | $18,331,000 | -1.1% | 164,494 | +0.8% | 5.81% | -8.5% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $18,113,000 | +46.3% | 176,175 | +25.2% | 5.74% | +35.2% |
| UTHR | UNITED THERAPEUTICS CORP DEL | $18,096,000 | +2.9% | 98,038 | 0.0% | 5.74% | -4.9% | |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $17,012,000 | -7.2% | 90,102 | -16.7% | 5.40% | -14.2% |
| OM | Buy | OUTSET MED INC | $16,454,000 | +77.0% | 332,800 | +78.9% | 5.22% | +63.6% |
| ARGX | Buy | ARGENX SEsponsored adr | $16,197,000 | +1.1% | 53,632 | +0.8% | 5.14% | -6.6% |
| DXCM | Sell | DEXCOM INC | $16,132,000 | +10.5% | 29,500 | -13.7% | 5.12% | +2.1% |
| INSP | Buy | INSPIRE MED SYS INC | $15,988,000 | +47.6% | 68,653 | +22.5% | 5.07% | +36.4% |
| ADPT | Buy | ADAPTIVE BIOTECHNOLOGIES COR | $15,005,000 | +42.4% | 441,466 | +71.2% | 4.76% | +31.7% |
| AXNX | Sell | AXONICS INC | $12,391,000 | -16.7% | 190,365 | -18.8% | 3.93% | -23.0% |
| GH | Buy | GUARDANT HEALTH INC | $11,958,000 | +240.7% | 95,660 | +238.5% | 3.79% | +215.0% |
| AGIO | AGIOS PHARMACEUTICALS INC | $10,869,000 | -16.3% | 235,513 | 0.0% | 3.45% | -22.6% | |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $9,199,000 | -1.6% | 52,000 | -10.2% | 2.92% | -9.1% |
| CANO | Buy | CANO HEALTH INC | $8,577,000 | +42.9% | 676,412 | +36.3% | 2.72% | +32.1% |
| AMWL | Buy | AMERICAN WELL CORPcl a | $8,211,000 | -10.3% | 901,300 | +23.9% | 2.60% | -17.1% |
| DRNA | Buy | DICERNA PHARMACEUTICALS INC | $8,196,000 | +36.3% | 406,525 | +152.3% | 2.60% | +26.0% |
| CMAX | Buy | CAREMAX INC | $5,958,000 | +22.3% | 616,770 | +63.3% | 1.89% | +13.0% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $5,359,000 | -62.1% | 29,544 | -57.9% | 1.70% | -65.0% |
| KYMR | KYMERA THERAPEUTICS INC | $2,173,000 | +21.1% | 37,000 | 0.0% | 0.69% | +11.9% | |
| CCCC | C4 THERAPEUTICS INC | $2,109,000 | +18.1% | 47,200 | 0.0% | 0.67% | +9.1% | |
| ARVN | ARVINAS INC | $1,890,000 | +6.7% | 23,000 | 0.0% | 0.60% | -1.5% | |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | $1,540,000 | +12.0% | 57,090 | 0.0% | 0.49% | +3.4% | |
| LYEL | LYELL IMMUNOPHARMA INC | $1,480,000 | -8.9% | 100,000 | 0.0% | 0.47% | -15.8% | |
| OLK | OLINK HLDG ABsponsored ads | $970,000 | -29.6% | 40,000 | 0.0% | 0.31% | -34.7% | |
| SEER | Exit | SEER INC | $0 | – | -83,500 | -100.0% | -0.94% | – |
| PRVA | Exit | PRIVIA HEALTH GROUP INC | $0 | – | -96,000 | -100.0% | -1.46% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-10-20
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IQVIA HLDGS INC | 12 | Q3 2023 | 9.6% |
| UNITED THERAPEUTICS CORP DEL | 12 | Q3 2023 | 8.7% |
| ALNYLAM PHARMACEUTICALS INC | 12 | Q3 2023 | 8.5% |
| NATERA INC | 12 | Q3 2023 | 8.5% |
| ARGENX SE | 12 | Q3 2023 | 7.0% |
| DEXCOM INC | 12 | Q3 2023 | 5.7% |
| OUTSET MED INC | 12 | Q3 2023 | 7.3% |
| AGIOS PHARMACEUTICALS INC | 12 | Q3 2023 | 7.2% |
| ADAPTIVE BIOTECHNOLOGIES COR | 12 | Q3 2023 | 5.1% |
| GUARDANT HEALTH INC | 12 | Q3 2023 | 3.8% |
View Eagle Health Investments LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-10-27 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-10 |
| 13F-HR | 2021-10-20 |
View Eagle Health Investments LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.